AIV Logo AIV Assistant

Loading...

 Logo Medpace Holdings, Inc. - MEDP Open Medpace Holdings, Inc. in new tab

580.37
P/E
41.65
EPS
14.32
P/B
58.09
ROE
0.74
Beta
1.41

580.3700

580.370

Daily: -0.72%
Key Metrics

Earnings date: Feb. 9, 2026

P/E: 41.65

EPS: 14.32

Book Value: 10.27

Price to Book: 58.09

Debt/Equity: 49.03

% Insiders: 0.207%

Growth

Revenue Growth: 0.24%

Earnings Growth: 0.28%

Estimates

Forward P/E: 47.76

Forward EPS: 12.49

 Logo About Medpace Holdings, Inc. - (MEDP)

Country: United States

Sector: Health Care

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion